← Career intelligence
Free · no sign-up · 3,138 priced deals

The deal tape

A precedent transactions set answers one question: what did somebody actually pay for a company like this one. Every row here is a US public target that filed a merger proxy or a going-private statement since 2020, with the offer per share, the premium to the unaffected price and the enterprise value multiples read from the filing itself rather than bought from a feed. Choose a sector, an industry code and a size band, and the quartiles above the list are the answer for that cut.

What it is not. Private-company deals, non-US targets and any transaction where no proxy was required leave nothing to read, so none of them are here. Neither are minority stakes or asset sales. Where a cross-check failed, the row still appears and says why, and it is held out of every median and quartile so one bad reading cannot move a number you would quote.

What this cut was bought at

Each measure counts the readings that survive its own cross-checks. Fewer than 4 is a coincidence, not a market.

MeasureDeals25thMedian75th
EV / LTM EBITDA3511.0x15.2x21.5x
EV / LTM revenue661.1x3.4x8.3x
Premium to unaffected price6129%39%67%
Premium to 30-day VWAP1330%48%63%

Read the EBITDA multiple against the revenue multiple before you use either. Where they disagree sharply the target was priced on growth rather than earnings, and the EBITDA line is the one that will not survive a second question.

Deals by year of announcement
0901802009: 15 deals, 2 clean on every measure2009152010: 159 deals, 30 clean on every measure20101592011: 151 deals, 70 clean on every measure20111512012: 148 deals, 93 clean on every measure20121482013: 144 deals, 92 clean on every measure20131442014: 148 deals, 59 clean on every measure20141482015: 161 deals, 81 clean on every measure20151612016: 180 deals, 103 clean on every measure20161802017: 161 deals, 90 clean on every measure20171612018: 176 deals, 93 clean on every measure20181762019: 171 deals, 90 clean on every measure20191712020: 101 deals, 44 clean on every measure20201012021: 172 deals, 85 clean on every measure20211722022: 127 deals, 77 clean on every measure20221272023: 121 deals, 62 clean on every measure20231212024: 125 deals, 82 clean on every measure20241252025: 159 deals, 84 clean on every measure20251592026: 80 deals, 41 clean on every measure202680
Clean on every measure In doubt on one measure or both
Median EV / LTM EBITDA by sector
Technology: 26.5x median across 7 dealsTechnology26.5xn=7Real Estate: 18.8x median across 5 dealsReal Estate18.8xn=5Industrials: 18.6x median across 5 dealsIndustrials18.6xn=5Healthcare: 16.8x median across 6 dealsHealthcare16.8xn=6Business Services: 15.1x median across 4 dealsBusiness Services15.1xn=4
Deals by sector
Technology: 30 dealsTechnology30Healthcare: 28 dealsHealthcare28Real Estate: 13 dealsReal Estate13Financials: 12 dealsFinancials12Business Services: 10 dealsBusiness Services10Industrials: 10 dealsIndustrials10Other: 7 dealsOther7Energy: 6 dealsEnergy6Materials: 5 dealsMaterials5Consumer & Retail: 2 dealsConsumer & Retail2Media & Telecom: 2 dealsMedia & Telecom2Utilities: 2 dealsUtilities2
Deals by buyer type
Financial sponsor: 2 dealsFinancial sponsor2Strategic: 79 dealsStrategic79Management / founder: 0 dealsManagement / founder0Controlling holder: 0 dealsControlling holder0Acquisition vehicle: 0 dealsAcquisition vehicle0Unclassified: 46 dealsUnclassified46
Deals by enterprise value
Under $250m: 39 dealsUnder $250m39$250m to $1bn: 23 deals$250m to $1bn23$1bn to $5bn: 35 deals$1bn to $5bn35$5bn to $20bn: 26 deals$5bn to $20bn26Over $20bn: 4 dealsOver $20bn4Not computed: 0 dealsNot computed0
Deals by industry code
Business Services & Software: 31 dealsBusiness Services & Sof…31Chemicals, Pharmaceuticals & Allied Products: 20 dealsChemicals, Pharmaceutic…20Holding & Other Investment Offices: 10 dealsHolding & Other Investm…10Depository Institutions: 9 dealsDepository Institutions9Health Services: 9 dealsHealth Services9Oil & Gas Extraction: 6 dealsOil & Gas Extraction6Electronics & Electrical Equipment: 6 dealsElectronics & Electrica…6Instruments, Medical Devices & Optical Goods: 5 dealsInstruments, Medical De…5Industrial Machinery & Computers: 4 dealsIndustrial Machinery & …4Transportation Equipment: 3 dealsTransportation Equipment3
TargetAcquirerIndustryEVEV / EBITDAEV / revenuePremiumFiling
IsoPlexis Corp
2022-12-21 · Public merger · $76.92 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price; EV / LTM revenue 160.7x above 60x
Berkeley Lights
Strategic
Industrials$3.0bnn.a.160.7x
61%
DEFM14A
Includes stock
Aerojet Rocketdyne Holdings, Inc.
2022-12-17 · Public merger · $58.00 a share
L3Harris Technologies, Inc.
Strategic
Industrials$4.6bn18.6x2.1x
n.a.
DEFM14A
All cash
Maxar Technologies Inc.
2022-12-15 · Public merger · $53.00 a share
Galileo Parent, Inc.
Unclassified
Technology$6.1bn13.3x3.5x
129%
DEFM14A
All cash
Malvern Bancorp, Inc.
2022-12-13 · Public merger · $7.80 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
First Bank
Strategic
Financials$6mn.a.5.2x
26%
DEFM14A
Includes stock
Coupa Software Inc
2022-12-11 · Public merger · $81.00 a share
Not named in the filing
Unclassified
Technology$5.3bnn.a.6.5x
25%
DEFM14A
All cash
Vivint Smart Home, Inc.
2022-12-06 · Public merger · $12.00 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
NRG Energy, Inc.
Strategic
Business Services$4.9bn7.7x3.0x
35%
DEFM14C
Includes stock
Apollo Endosurgery, Inc.
2022-11-29 · Public merger · $10.00 a share
Boston Scientific
Strategic
Healthcare$383mn.a.5.3x
67%
DEFM14A
All cash
CalciMedica, Inc.
2022-11-21 · Public merger · $0.50 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Inc.
Strategic
Healthcare-$33mn.a.n.a.
n.a.
DEFM14A
Includes stock
First Seacoast Bancorp
2022-11-21 (filed) · Public merger · $10.00 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price; no balance sheet at announcement: EV = equity value
Not named in the filing
Unclassified
Financials$61mn.a.n.a.
n.a.
DEFM14A
Includes stock
Opiant Pharmaceuticals, Inc.
2022-11-13 · Public merger · $20.00 a share
Indivior Inc.
Strategic
Healthcare$80mn.a.3.6x
111%
DEFM14A
All cash
Verde Clean Fuels, Inc.
2022-11-10 (filed) · Public merger · $10.00 a share
Not named in the filing
Unclassified
Materials$218mn.a.n.a.
n.a.
DEFM14A
All cash
Ouster, Inc.
2022-11-04 · Public merger · $1.14 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Velodyne Lidar USA, Inc.
Strategic
Industrials$93mn.a.2.2x
n.a.
DEFM14A
Includes stock
Velodyne Lidar, Inc.
2022-11-04 · Public merger · $1.14 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Ouster, Inc.
Strategic
Industrials$51mn.a.1.1x
n.a.
DEFM14A
Includes stock
Benefitfocus, Inc.
2022-11-01 · Public merger · $10.50 a share
Voya Financial, Inc.
Strategic
Technology$310m20.1x1.2x
67%
DEFM14A
All cash
Renovacor, Inc.
2022-10-31 (filed) · Public merger · $9.99 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Rocket’s Merger Subs
Unclassified
Healthcare$107mn.a.n.a.
n.a.
DEFM14A
Includes stock
Appreciate Holdings, Inc.
2022-10-28 (filed) · Public merger · $1.50 a share
Not named in the filing
Unclassified
Real Estate$9mn.a.n.a.
n.a.
DEFM14A
All cash
Altra Industrial Motion Corp.
2022-10-26 · Public merger · $62.00 a share
Regal Rexnord Corporation
Strategic
Industrials$4.9bn25.0x2.5x
66%
73% to VWAP
DEFM14A
All cash
UserTesting, Inc.
2022-10-26 · Public merger · $7.50 a share
Thunder Holdings, LLC, Inc.
Strategic
Technology$921mn.a.n.a.
95%
DEFM14A
All cash
Old Ayala, Inc
2022-10-18 · Public merger · $4.75 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Advaxis, Inc.
Strategic
Healthcare$59mn.a.34.6x
n.a.
DEFM14A
Includes stock
HV Bancorp, Inc.
2022-10-18 · Public merger · $30.50 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Citizens Financial Services, Inc.
Strategic
Financials$41mn.a.51.6x
n.a.
DEFM14A
Includes stock
Aveo Pharmaceuticals, Inc.
2022-10-18 · Public merger · $15.00 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Not named in the filing
Unclassified
Healthcare$442mn.a.4.7x
43%
DEFM14A
Includes stock
EUDA Health Holdings Ltd
2022-10-13 (filed) · Public merger · $10.00 a share
Not named in the filing
Unclassified
Healthcare$111mn.a.10.5x
n.a.
DEFM14A
All cash
Albertsons Companies, Inc.
2022-10-13 · Public merger · $34.10 a share
The Kroger Co.
Strategic
Consumer & Retail$23bn5.3x0.3x
33%
30% to VWAP
DEFM14C
All cash
SeaSpine Holdings Corp
2022-10-10 · Public merger · $7.64 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Orthofix Medical Inc.
Strategic
Healthcare$237mn.a.1.0x
n.a.
DEFM14A
Includes stock
ForgeRock, Inc.
2022-10-10 · Public merger · $23.25 a share
Not named in the filing
Unclassified
Technology$774mn.a.3.8x
53%
DEFM14A
All cash

How to use a set like this

Cut to the narrowest set that still holds eight or ten deals, then quote the range rather than the median. An interviewer who asks where software takes out will accept a spread and press on a single number, because the single number implies a precision the set does not have. Say which deals sit at each end and why: the top of a range is usually a contested auction or a strategic buyer with synergies, the bottom a controlling holder buying in the minority.

Premiums move with the reference price, not only with the deal. A bidder quotes the period that flatters the offer, so read the premium to the unaffected close beside the premium to the thirty-day average and notice when they diverge.

What each column means

Enterprise value.
Offer per share times shares outstanding, plus net debt at the last balance sheet before the merger agreement. It is blank where either piece was missing, and those rows are in the “not computed” band rather than in a size they never earned.
Premium.
The offer against the unaffected price, which is the last close before the deal became known. Where the filing states a premium to the thirty-day volume-weighted average, that is shown next to it.
Deal type.
A take-private is bought by an affiliate, which is what triggers the Schedule 13E-3 and the fuller disclosure that comes with it. A public merger is an arm’s-length buyer, disclosed through the merger proxy.
In doubt.
A cross-check the reading could not satisfy: an equity value far from the fee-table figure, a multiple outside any sane band, or consideration that is partly stock so the per-share cash figure is not the price. The row stays visible, and it is set aside only for the measures the doubt reaches. A cash-and-stock deal cannot price a multiple and still states a premium the filing itself computed, so it counts in one and not the other.

Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More